RSC Advances,
Journal Year:
2024,
Volume and Issue:
14(26), P. 18453 - 18458
Published: Jan. 1, 2024
Asymmetric
catalytic
processes
promoted
by
N-heterocyclic
carbenes
(NHCs)
hold
great
potential
for
the
sustainable
preparation
of
chiral
molecules.
However,
catalyzing
reactions
manipulating
reactive
intermediates
is
challenging.
We
report
herein
that
known
NHC-catalyzed
[3
+
2]
annulation
reaction
between
ketimine
and
enal
can
also
be
turned
into
a
[2
3]
highly
enantioselective
direct
synthesis
trifluoroethyl
3,2'-spirooxindole
γ-lactams
(4)
through
timely
catalysis
intermediates.
DFT
calculations
revealed
this
transformation
included
key
step
nucleophilic
attack
Breslow
intermediate
M2
derived
from
NHC
(2)
to
unattacked
(1).
Our
study
demonstrates
it
possible
tune
desired
selectivities
dynamic
catalysts
Pharmacological Research,
Journal Year:
2024,
Volume and Issue:
207, P. 107327 - 107327
Published: July 28, 2024
Evidence
shows
that
tropomodulin
1
(TMOD1)
is
a
powerful
diagnostic
marker
in
the
progression
of
several
cancer
types.
However,
regulatory
mechanism
TMOD1
tumor
still
unclear.
Here,
we
showed
was
highly
expressed
acute
myeloid
leukemia
(AML)
specimens,
and
TMOD1-silencing
inhibited
cell
proliferation
by
inducing
autophagy
AML
THP-1
MOLM-13
cells.
Mechanistically,
C-terminal
region
directly
bound
to
KPNA2,
TMOD1-overexpression
promoted
KPNA2
ubiquitylation
reduced
levels.
In
contrast,
increased
levels
facilitated
nuclear
transfer
then
subsequently
induced
increasing
nucleocytoplasmic
transport
p53
AMPK
activation.
KPNA2/p53
inhibitors
attenuated
silencing
Silencing
also
growth
elevating
KPNA2-mediated
nude
mice
bearing
xenografts.
Collectively,
our
data
demonstrated
could
be
novel
therapeutic
target
for
treatment.